Bioinspired chemical probe approach targeting telomerase reverse transcriptase
Bioinspired chemical probe approach targeting telomerase reverse transcriptase
批准号:
10219211
负责人:
Stephen J. Kron
金额:
$38.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-05-31
关键词:
Active SitesAcuteAddressAdultAffectAgingAmericanAttentionBiologicalBiological AssayBuffersCT26Cancer BiologyCancer Cell GrowthCatalytic DomainCell AgingCell NucleusCell ProliferationCell SurvivalCell divisionCellsCellular StressChemicalsChromosomesClinicCollaborationsColon CarcinomaComplexDNA DamageDNA Double Strand BreakDNA RepairDNA biosynthesisDefectDevelopmentDiagnosisDouble Strand Break RepairEvaluationExperimental NeoplasmsGenerationsGeneticGenetic TranscriptionGoalsGrowthHandHumanIonizing radiationKnowledgeLengthLibrariesLinkMagicMaintenanceMalignant NeoplasmsMethodsMitochondriaModelingModificationMolecularMolecular ProbesMusNatural ProductsNeoplasm MetastasisOxidative StressPathway interactionsPharmaceutical PreparationsProcessRNA-Directed DNA PolymeraseRadiationRadiation Induced DNA DamageRadiation ToleranceRadiation-Sensitizing AgentsRecurrenceRepetitive SequenceReportingResearchRoleStructureTelomeraseTelomerase InhibitorTelomere Length MaintenanceTelomere MaintenanceTherapeuticTissuesTranslatingTranslationsUrsidae FamilyWorkanalogbasecancer cellcancer stem cellcancer survivalcancer therapycell transformationchemical synthesisclinical candidateconventional therapydesignearly onsetgenetic approachgenotoxicityhigh rewardhigh riskimprovedinhibitor/antagonistinsightnovelpre-clinicalpreservationprogramsresponsesenescencesmall moleculesuccesstargeted treatmenttelomeretooltumortumor progressiontumorigenesisuncontrolled cell growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Telomerase has attracted significant attention as a potential target for understanding the aging process and for
the treatment of cancer, since telomeres and telomerase have important roles in the transformation and
survival of cancer cells. Previous prevailing strategies for targeting telomerase were based on the assumption
that in cancer cells, telomere-length maintenance was the sole pro-survival function of this assembly. However,
increasingly evidence strongly indicates that a) inhibition of the telomere-lengthening activity of telomerase is
not a magic bullet treatment for cancer, and b) there is a much larger role for telomerase in key cellular
pathways and these functions are not well understood. Although there have been promising clinical candidates
among telomerase inhibitors, the translation of telomerase-targeted therapies to the clinic remains elusive and
frustratingly slow. This lack of progress is due in part to the growing list of unanswered questions surrounding
telomerase and its role in cancer biology; notably, that hTERT has non-canonical functions separate from
its telomere-lengthening activity that are linked to cancer cell survival. This proposal builds on the
collaboration between the Scheidt and Kron research groups to bring our expertise in chemical synthesis and
cancer biology to bear on key gaps in the knowledge surrounding hTERT, its non-canonical functions, and its
involvement in cancer cell survival. We have discovered that small molecules based on the natural product
chrolactomycin inhibit telomerase and provide a unique platform for probe development. Based on robust
chemical and biological results, we propose to first develop enhanced small molecule probes with improved
efficacy. These compounds will enable precise covalent modification of hTERT catalytic function without
perturbing the overall complex assembly. The following Aims will focus on exploring the use of these new tools
to explore the role(s) of telomerase in DNA damage repair and cell senescence through in-depth analysis of
multiple functions of telomerase as a buffer of cell stress and determinant of cell immortality. The long-term
goal of this project is to understand and leverage the molecular basis for how these natural product-based
molecular tools impact the telomere lengthening and most importantly, non-canonical functions of hTERT.
Ultimately, this new knowledge will drive the development of new understanding of telomerase and its
biological roles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation
-
批准号:10718390
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2023
-
负责人:Stephen J. Kron
-
依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
-
批准号:10330483
-
项目类别:
-
资助金额:$57.67万
-
财政年份:2021
-
负责人:Stephen J. Kron
-
依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
-
批准号:10182630
-
项目类别:
-
资助金额:$60.2万
-
财政年份:2021
-
负责人:Stephen J. Kron
-
依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
-
批准号:10547820
-
项目类别:
-
资助金额:$57.7万
-
财政年份:2021
-
负责人:Stephen J. Kron
-
依托单位:
Bioinspired chemical probe approach targeting telomerase reverse transcriptase
-
批准号:10627813
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Lipid signaling in cellular senescence and tissue aging
-
批准号:10474541
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Lipid signaling in cellular senescence and tissue aging
-
批准号:10263366
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Bioinspired chemical probe approach targeting telomerase reverse transcriptase
-
批准号:10411995
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Lipid signaling in cellular senescence and tissue aging
-
批准号:10667537
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Lipid signaling in cellular senescence and tissue aging
-
批准号:10095615
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2020
-
负责人:Stephen J. Kron
-
依托单位:
Targets of Reactive Lipid Species regulating DNA damage response and cell senescence
-
批准号:10196988
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2017
-
负责人:Stephen J. Kron
-
依托单位:
Targets of Reactive Lipid Species regulating DNA damage response and cell senescence
-
批准号:9517802
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2017
-
负责人:Stephen J. Kron
-
依托单位:
Image-guided radiation-induced permeability (IGRIP) for IGDD
-
批准号:9111848
-
项目类别:
-
资助金额:$49.52万
-
财政年份:2015
-
负责人:Stephen J. Kron
-
依托单位:
Image-guided radiation-induced permeability (IGRIP) for IGDD
-
批准号:9283383
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2015
-
负责人:Stephen J. Kron
-
依托单位:
Image-guided radiation-induced permeability (IGRIP) for IGDD
-
批准号:8972679
-
项目类别:
-
资助金额:$51.24万
-
财政年份:2015
-
负责人:Stephen J. Kron
-
依托单位:
PARP Inhibition To Enhance Induction for Head and Neck Cancer
-
批准号:9119779
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:Stephen J. Kron
-
依托单位:
PARP Inhibition To Enhance Induction for Head and Neck Cancer
-
批准号:8517320
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:Stephen J. Kron
-
依托单位:
PARP Inhibition To Enhance Induction for Head and Neck Cancer
-
批准号:8738622
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2013
-
负责人:Stephen J. Kron
-
依托单位:
PARP Inhibition To Enhance Induction for Head and Neck Cancer
-
批准号:8927559
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:Stephen J. Kron
-
依托单位:
Radiation response within the tumor microenvironment
-
批准号:8519977
-
项目类别:
-
资助金额:$88.35万
-
财政年份:2011
-
负责人:Stephen J. Kron
-
依托单位:
海外基金